van Baren N - Search Results

1

Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients.

Seremet T, Koch A, Jansen Y, Schreuer M, Wilgenhof S, Del Marmol V, Liènard D, Thielemans K, Schats K, Kockx M, Van Criekinge W, Coulie PG, De Meyer T, van Baren N, Neyns B. Seremet T, et al. Among authors: van baren n. J Transl Med. 2016 Aug 2;14(1):232. doi: 10.1186/s12967-016-0990-x. J Transl Med. 2016. PMID: 27484791 Free PMC article.

2

Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor.

Ikeda H, Lethé B, Lehmann F, van Baren N, Baurain JF, de Smet C, Chambost H, Vitale M, Moretta A, Boon T, Coulie PG. Ikeda H, et al. Among authors: van baren n. Immunity. 1997 Feb;6(2):199-208. doi: 10.1016/s1074-7613(00)80426-4. Immunity. 1997. PMID: 9047241 Free article.

3

PRAME, a gene encoding an antigen recognized on a human melanoma by cytolytic T cells, is expressed in acute leukaemia cells.

van Baren N, Chambost H, Ferrant A, Michaux L, Ikeda H, Millard I, Olive D, Boon T, Coulie PG. van Baren N, et al. Br J Haematol. 1998 Sep;102(5):1376-9. doi: 10.1046/j.1365-2141.1998.00982.x. Br J Haematol. 1998. PMID: 9753074 Free article.

4

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1.

Marchand M, van Baren N, Weynants P, Brichard V, Dréno B, Tessier MH, Rankin E, Parmiani G, Arienti F, Humblet Y, Bourlond A, Vanwijck R, Liénard D, Beauduin M, Dietrich PY, Russo V, Kerger J, Masucci G, Jäger E, De Greve J, Atzpodien J, Brasseur F, Coulie PG, van der Bruggen P, Boon T. Marchand M, et al. Among authors: van baren n, van der bruggen p. Int J Cancer. 1999 Jan 18;80(2):219-30. doi: 10.1002/(sici)1097-0215(19990118)80:2<219::aid-ijc10>3.0.co;2-s. Int J Cancer. 1999. PMID: 9935203 Free article. Clinical Trial.

5

Genes encoding tumor-specific antigens are expressed in human myeloma cells.

van Baren N, Brasseur F, Godelaine D, Hames G, Ferrant A, Lehmann F, André M, Ravoet C, Doyen C, Spagnoli GC, Bakkus M, Thielemans K, Boon T. van Baren N, et al. Blood. 1999 Aug 15;94(4):1156-64. Blood. 1999. PMID: 10438702 Free article.

6

High frequency of autologous anti-melanoma CTL directed against an antigen generated by a point mutation in a new helicase gene.

Baurain JF, Colau D, van Baren N, Landry C, Martelange V, Vikkula M, Boon T, Coulie PG. Baurain JF, et al. Among authors: van baren n. J Immunol. 2000 Jun 1;164(11):6057-66. doi: 10.4049/jimmunol.164.11.6057. J Immunol. 2000. PMID: 10820291

7

Biological and clinical developments in melanoma vaccines.

Marchand M, Brichard V, van Baren N, Coulie PG. Marchand M, et al. Among authors: van baren n. Expert Opin Biol Ther. 2001 May;1(3):497-510. doi: 10.1517/14712598.1.3.497. Expert Opin Biol Ther. 2001. PMID: 11727521 Review.

8

Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen.

Coulie PG, Karanikas V, Lurquin C, Colau D, Connerotte T, Hanagiri T, Van Pel A, Lucas S, Godelaine D, Lonchay C, Marchand M, Van Baren N, Boon T. Coulie PG, et al. Among authors: van pel a, van baren n. Immunol Rev. 2002 Oct;188:33-42. doi: 10.1034/j.1600-065x.2002.18804.x. Immunol Rev. 2002. PMID: 12445279 Review.

9

Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus.

Karanikas V, Lurquin C, Colau D, van Baren N, De Smet C, Lethé B, Connerotte T, Corbière V, Demoitié MA, Liénard D, Dréno B, Velu T, Boon T, Coulie PG. Karanikas V, et al. Among authors: van baren n. J Immunol. 2003 Nov 1;171(9):4898-904. doi: 10.4049/jimmunol.171.9.4898. J Immunol. 2003. PMID: 14568971

10

Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen.

Lonchay C, van der Bruggen P, Connerotte T, Hanagiri T, Coulie P, Colau D, Lucas S, Van Pel A, Thielemans K, van Baren N, Boon T. Lonchay C, et al. Among authors: van pel a, van baren n, van der bruggen p. Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2(Suppl 2):14631-8. doi: 10.1073/pnas.0405743101. Epub 2004 Sep 27. Proc Natl Acad Sci U S A. 2004. PMID: 15452345 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page